How to control residual risk during the statin era?

Journal of the American College of Cardiology

Volumn 66, Issue 16, 2015, Pages 1848-

  Koh, Kwang Kon ^a  

^a Gachon University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR RISK; DRUG EFFICACY; DYSLIPIDEMIA; HIGH RISK PATIENT; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LETTER; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; PREDICTION; PRIORITY JOURNAL; PROTEIN TARGETING; RISK REDUCTION; BLOOD; DYSLIPIDEMIAS;

CHOLESTEROL, HDL; DYSLIPIDEMIAS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; TRIGLYCERIDES;

EID: 84944089054     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.07.072     Document Type: Letter

References (5)

1. G.G. Schwartz, M. Abt, W. Bao, and et al. Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins J Am Coll Cardiol 65 2015 2267 2275
2. S. Lim, Y.M. Park, I. Sakuma, and K.K. Koh How to control residual cardiovascular risk despite statin treatment: focusing on HDL-cholesterol Int J Cardiol 166 2013 8 14
3. B.G. Nordestgaard, and A. Varbo Triglycerides and cardiovascular disease Lancet 384 2014 626 635
4. M.V. Holmes, F.W. Asselbergs, T.M. Palmer, and et al. Mendelian randomization of blood lipids for coronary heart disease Eur Heart J 36 2014 539 550
5. S. Lim, P.C. Oh, I. Sakuma, and K.K. Koh How to balance cardiorenometabolic benefits and risks of statins Atherosclerosis 235 2014 644 648